That seems a pretty big premium to the SP, which would make sense if you were buying the company... I do remember something like that at the time.
I was looking for the announcement to see if they were already holding the extra 50m shares, but having phone issues...
- Forums
- ASX - By Stock
- API
- News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln
News: API Australian Pharmaceutical Industries Posts FY NPAT Of $56.6 Mln, page-22
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add API (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online